Publications by authors named "Christina To"

Claim this Profile
P
Plain language summary of the ZUMA-7 study of axicabtagene ciloleucel versus standard of care for people with relapsed or refractory large B-cell lymphoma.
Frederick L Locke, Jason R Westin, Christina To

Future Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor gene expression signatures associated with outcome in large B-cell lymphoma treated with CD19-directed CAR T-cell therapy (axicabtagene ciloleucel).
Yuan Tian, Justin Budka, Frederick L Locke, Jason R Westin, Christina To, Simone Filosto

Front Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of subsequent antilymphoma therapies after second-line axicabtagene ciloleucel or standard of care in ZUMA-7.
Armin Ghobadi, Javier Munoz, Jason R Westin, Frederick L Locke, David B Miklos, Christina To

Blood Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume.
Frederick L Locke, Olalekan O Oluwole, John Kuruvilla, Catherine Thieblemont, Franck Morschhauser, Simone Filosto, Christina To

Blood· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma.
Frederick L Locke, Simone Filosto, Justin Chou, Saran Vardhanabhuti, Regis Perbost, Christina To

Nat Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7).
Simone Filosto, Saran Vardhanabhuti, Miguel A Canales, Xavier Poiré, Lazaros J Lekakis, Christina To

Blood Cancer Discov· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axicabtagene Ciloleucel in Combination with the 4-1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11.
Michael D Jain, David B Miklos, Caron A Jacobson, John M Timmerman, Jennifer Sun, Christina To, Simone Filosto

Clin Cancer Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axicabtagene Ciloleucel in Large B-Cell Lymphoma. Reply.
Jason R Westin, Christina To, Frederick L Locke

N Engl J Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.
Jason R Westin, Olalekan O Oluwole, Marie José Kersten, David B Miklos, Miguel-Angel Perales, Tom van Meerten, Simone Filosto, Christina To

N Engl J Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality-Adjusted Time without Symptoms or Toxicity: Analysis of Axicabtagene Ciloleucel versus Standard of Care in Patients with Relapsed/Refractory Large B Cell Lymphoma.
Marie José Kersten, Yao Qiao, Ruchit Shah, Caitlyn Solem, Julia Thornton Snider, Christina To

Transplant Cell Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma.
Jason R Westin, Frederick L Locke, Michael Dickinson, Armin Ghobadi, Mahmoud Elsawy, Tom van Meerten, Patrick Johnston, Simone Filosto, Christina To

Clin Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma.
Mahmoud Elsawy, Julio C Chavez, Irit Avivi, Jean-François Larouche, Luciano Wannesson, Julia Thornton Snider, Christina To

Blood· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
Frederick L Locke, David B Miklos, Caron A Jacobson, Miguel-Angel Perales, Marie-José Kersten, Tom van Meerten, Simone Filosto, Christina To

N Engl J Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma.
William W Tseng, Shouhao Zhou, Christina A To, Peter F Thall, Alexander J Lazar

Cancer· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Masquerade without a mass: an unusual cause of severe acute pancreatitis.
Christina A To, Michael M Quigley, Alan Saven, Laura Nicholson

J Gastrointest Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cryptococcal osteomyelitis and meningitis in a patient with non-hodgkin's lymphoma treated with PEP-C.
Christina A To, Robert W Hsieh, James Scott McClellan, Walter Howard, Nancy J Fischbein

BMJ Case Rep· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multiple choice answer?
Christina To, Jason Napolitano

J Hosp Med· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guiding the "misguided" - functional conditioning of dendritic cells for the DC-based immunotherapy against tumours.
Fang-Ping Huang, Yu-Xiao Chen, Christina Kw To

Eur J Immunol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic autoimmune disease induced by dendritic cells that have captured necrotic but not apoptotic cells in susceptible mouse strains.
Liang Ma, Kwok-Wah Chan, Nigel J Trendell-Smith, Adrian Wu, Lina Tian, Christina K W To, David I Stott

Eur J Immunol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis